Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Jerusalem Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14.51	11.74	6.59	7.73	5.44	1.96
Short-Term Investments	-	0.09	0.05	0.03	0.03	0.04
Trading Asset Securities	-	-	-	0.03	0.03	0.02
Cash & Short-Term Investments	14.51	11.84	6.64	7.79	5.49	2.02
Cash Growth	67.11%	78.27%	-14.72%	41.69%	171.63%	67.77%
Accounts Receivable	28.82	28.25	29.95	31.63	30.81	24.2
Other Receivables	-	-	0	-	-	0.72
Receivables	28.82	28.25	29.95	31.63	30.81	24.92
Inventory	10.46	8.34	10.41	10.88	14.76	14.44
Prepaid Expenses	-	0.31	0.51	0.4	0.73	0.73
Other Current Assets	4.11	2.8	3.1	2.22	3.33	3.2
Total Current Assets	57.91	51.54	50.61	52.91	55.12	45.3
Property, Plant & Equipment	27.89	25.9	27.13	25.48	27.47	27.15
Long-Term Investments	11.2	7.24	6.42	3.22	0.7	1.22
Other Intangible Assets	2.2	1.8	1.55	1.52	3.04	3.53
Long-Term Deferred Tax Assets	0.44	0.4	0.28	0.27	0.2	0.16
Other Long-Term Assets	2.45	2.27	0.32	0.32	0.37	0.36
Total Assets	102.09	89.15	86.32	83.72	86.89	77.71
Accounts Payable	7.83	3.29	3.48	6.56	5.11	4.35
Accrued Expenses	-	3.58	2.33	1.32	1.99	1.39
Short-Term Debt	0.68	0.46	0.52	0.65	0.78	1.69
Current Portion of Long-Term Debt	-	0.61	1.13	0.69	0.57	0.6
Current Portion of Leases	0.27	0.3	0.48	0.36	0.55	0.64
Current Income Taxes Payable	2.12	1.29	2.42	2.67	1.66	0.18
Other Current Liabilities	6.14	2.46	1.95	1.46	2.3	2
Total Current Liabilities	17.04	12	12.32	13.7	12.97	10.84
Long-Term Debt	-	-	-	-	-	0.38
Long-Term Leases	0.07	0.14	0.33	0.49	0.72	0.55
Long-Term Unearned Revenue	0.51	0.29	-	-	-	-
Total Liabilities	23.5	17.55	17.44	18.49	18.32	16.07
Common Stock	18	18	18	18	18	18
Additional Paid-In Capital	3.72	3.72	3.72	3.72	3.72	3.72
Retained Earnings	45.32	42.83	39.6	34.9	29.89	24.73
Comprehensive Income & Other	10.5	6.04	6.52	7.65	14.87	12.87
Total Common Equity	77.53	70.6	67.84	64.27	66.47	59.32
Minority Interest	1.06	1.01	1.04	0.96	2.1	2.32
Shareholders' Equity	78.59	71.61	68.88	65.23	68.57	61.64
Total Liabilities & Equity	102.09	89.15	86.32	83.72	86.89	77.71
Total Debt	1.01	1.51	2.47	2.18	2.63	3.85
Net Cash (Debt)	13.5	10.32	4.17	5.6	2.86	-1.83
Net Cash Growth	102.19%	147.75%	-25.64%	95.69%	-	-
Net Cash Per Share	0.75	0.57	0.23	0.31	0.16	-0.10
Filing Date Shares Outstanding	18.01	18	18	18	18	18
Total Common Shares Outstanding	18.01	18	18	18	18	18
Working Capital	40.87	39.53	38.28	39.2	42.16	34.46
Book Value Per Share	4.30	3.92	3.77	3.57	3.69	3.30
Tangible Book Value	75.33	68.8	66.29	62.75	63.43	55.8
Tangible Book Value Per Share	4.18	3.82	3.68	3.49	3.52	3.10
Land	-	9.49	10.63	9.24	8.31	8.13
Buildings	-	15.42	15.64	15.73	16.34	15.87
Machinery	-	30.8	29.47	28.78	31.82	29.69

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.